Hepatitis C Overview

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 154 CE courses, most popular
$95Add to cart
Pick Your Courses
Up to 8 CE hours
$50Add to cart
Individual course$20Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Acute Viral Hepatitis Panel. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Acute Viral Hepatitis Panel (online CE course)
Hepatitis C Overview

The hepatitis C virus (HCV) is of the genus Hepacivirus, family Flaviviridae. It is an RNA virus with at least six different genotypes. HCV is responsible for between 15% to 20% of all cases of acute hepatitis. It is also the most common cause of chronic liver disease. HCV is also the most common cause of post-transfusion hepatitis in the US.
In 2019, a total of 4,136 new cases of acute hepatitis C were reported to the CDC from 44 states. Based on this number, the CDC estimates a total of 57,500 new acute cases of HCV in 2019.
HCV is now more prevalent in the US than HBV. The number of chronic HBV infections is estimated to be around 862,000 while the number of chronic HCV infections is estimated to be around 2.4 million in the US. This is partially due to the lack of a vaccine against HCV, as well as a higher rate of chronic HCV infections compared to HBV.
HCV is transmitted mainly through exposure to infectious blood or bodily fluids. Since this is similar to HBV, the modes of transmission and the populations at risk are similar between the two diseases.